<DOC>
	<DOCNO>NCT02751060</DOCNO>
	<brief_summary>The purpose study determine whether expression level miR-320a effective biomarker evaluate diagnosis , prognosis treatment effect coronary heart disease .</brief_summary>
	<brief_title>Evaluation Plasma Non-coding RNAs Biomarkers Coronary Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>1 . 18 year age old ; 2. recent symptom coronary heart disease within 7 day ; 3. meet one follow condition : A. clinical history typical ischemic chest pain ( 5 minute persistent chest pain ) ; B. serum cardiac biomarkers positive ( TnT/I creatine kinase peak great 99 % URL ) ; C. Electrocardiogram change myocardial ischemia . 1. pregnant woman plan ; 2. participate drug clinical trial within 3 month ; 3. patient lifethreatening complication , researcher determine survival time patient 1 year ; 4. serious neurological disease ( Alzheimer 's disease , Parkinson syndrome , progressive low limb deaf patient ) ; 5. previous history cancer tumor , pathological examination confirm precancerous lesion ( breast ductal carcinoma situ , atypical hyperplasia cervix ) ; 6. patient refuse comply requirement study complete research work ; 7. accord researcher , patient complete study comply requirement study ( reason management reason ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>